<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We used label-free quantitative proteomics with the insoluble fractions from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients to gain further insight into the utility of profiling altered protein expression as a potential biomarker for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The insoluble fractions were prepared from paired <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>/<z:mpath ids='MPATH_458'>normal</z:mpath> biopsies from 13 patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (stages I to IV) </plain></SENT>
<SENT sid="2" pm="."><plain>Fifty-six proteins identified in data pooled from the 13 cases were differentially expressed between the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="3" pm="."><plain>The connections between these proteins are involved in reciprocal networks related to <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence based on <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e>, and skeletal and <z:e sem="disease" ids="C0026848" disease_type="Disease or Syndrome" abbrv="">muscular disorders</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>To assess their potential utility as biomarkers, the relative expression levels of the proteins were validated using personal proteomics and a heat map to compare five individual <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples with five <z:mpath ids='MPATH_458'>normal</z:mpath> tissue samples </plain></SENT>
<SENT sid="5" pm="."><plain>Further validation of a panel of proteins (KRT5, JUP, TUBB, and COL6A1) using western blotting confirmed the differential expression </plain></SENT>
<SENT sid="6" pm="."><plain>These proteins gave specific network information for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and yielded a panel of novel markers and potential targets for treatment </plain></SENT>
<SENT sid="7" pm="."><plain>It is anticipated that the experimental approach described here will increase our understanding of the membrane environment in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, which may provide direction for making diagnoses and prognoses through molecular biomarker targeting </plain></SENT>
</text></document>